Total Payments
$10,213
2024 Payments
$1,481
Companies
38
Transactions
455
Medicare Patients
12,351
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$10,003 (97.9%)
Education$210.75 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,003 | 450 | 97.9% |
| Education | $210.75 | 5 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,587 | 84 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $1,096 | 5 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $961.11 | 42 | $0 (2024) |
| LEO Pharma Inc. | $790.68 | 57 | $0 (2024) |
| Janssen Biotech, Inc. | $658.57 | 34 | $0 (2024) |
| Dermavant Sciences, Inc. | $566.21 | 25 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $489.95 | 17 | $0 (2024) |
| PFIZER INC. | $401.97 | 21 | $0 (2024) |
| GENZYME CORPORATION | $372.81 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $353.81 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,481 | 69 | ABBVIE INC. ($419.03) |
| 2023 | $1,669 | 73 | Dermavant Sciences, Inc. ($337.76) |
| 2022 | $1,874 | 106 | LEO Pharma Inc. ($410.27) |
| 2021 | $1,337 | 58 | MERZ NORTH AMERICA, INC. ($332.64) |
| 2020 | $462.98 | 26 | AbbVie Inc. ($225.44) |
| 2019 | $1,532 | 44 | Merz North America, Inc. ($763.35) |
| 2018 | $724.91 | 30 | Janssen Scientific Affairs, LLC ($124.12) |
| 2017 | $1,133 | 49 | Promius Pharma LLC ($211.97) |
All Payment Transactions
455 individual payment records from CMS Open Payments — Page 2 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Inflammation | ||||||
| 08/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 07/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Immunology | ||||||
| 07/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Inflammation | ||||||
| 07/02/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 06/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Inflammation | ||||||
| 06/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: DERMATOLOGY | ||||||
| 06/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: DERMATOLOGY | ||||||
| 05/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Inflammation | ||||||
| 05/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: DERMATOLOGY | ||||||
| 04/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: DERMATOLOGY | ||||||
| 04/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,387 | 8,904 | $912,883 | $323,498 |
| 2022 | 21 | 3,022 | 6,565 | $840,773 | $299,746 |
| 2021 | 21 | 3,029 | 6,509 | $838,282 | $300,410 |
| 2020 | 19 | 2,913 | 6,223 | $761,039 | $267,418 |
Total Patients
12,351
Total Services
28,201
Medicare Billing
$1.2M
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 853 | 1,249 | $265,564 | $94,294 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 406 | $121,708 | $44,601 | 36.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 435 | 496 | $122,594 | $44,291 | 36.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 495 | 711 | $115,239 | $36,605 | 31.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 290 | 386 | $51,751 | $18,766 | 36.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 177 | 177 | $47,399 | $15,945 | 33.6% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 18 | 101 | $29,080 | $11,206 | 38.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 68 | 90 | $24,851 | $9,169 | 36.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 303 | 1,329 | $21,163 | $8,278 | 39.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 105 | 136 | $16,601 | $6,604 | 39.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 76 | 146 | $20,142 | $6,541 | 32.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 69 | 69 | $11,879 | $4,106 | 34.6% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 13 | 3,000 | $12,000 | $3,890 | 32.4% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 22 | 57 | $9,629 | $3,616 | 37.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $10,999 | $3,614 | 32.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 21 | $6,460 | $2,375 | 36.8% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 11 | 11 | $6,168 | $2,313 | 37.5% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 18 | 18 | $5,448 | $2,189 | 40.2% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 20 | 22 | $5,454 | $1,878 | 34.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 122 | $4,065 | $1,513 | 37.2% |
| 69100 | Biopsy of ear | Office | 2023 | 16 | 17 | $4,012 | $1,450 | 36.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 105 | 312 | $676.48 | $253.98 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 793 | 1,199 | $261,900 | $92,289 | 35.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 394 | 441 | $112,868 | $39,905 | 35.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 435 | 616 | $102,841 | $33,067 | 32.2% |
About Ronald Brancaccio
Ronald Brancaccio is a Specialist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174578769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ronald Brancaccio has received a total of $10,213 in payments from pharmaceutical and medical device companies, with $1,481 received in 2024. These payments were reported across 455 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($10,003).
As a Medicare-enrolled provider, Brancaccio has provided services to 12,351 Medicare beneficiaries, totaling 28,201 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Brooklyn, NY
- Active Since 05/23/2006
- Last Updated 08/14/2012
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174578769
Products in Payments
- XEOMIN (Biological) $763.35
- Winlevi (Drug) $659.56
- DUPIXENT (Biological) $610.69
- VTAMA (Drug) $566.21
- TREMFYA (Drug) $546.26
- SKYRIZI (Biological) $518.57
- ADBRY (Biological) $472.28
- RINVOQ (Biological) $413.40
- Otezla (Drug) $363.65
- Humira (Biological) $341.22
- EUCRISA (Drug) $333.47
- ENSTILAR (Drug) $318.40
- COSENTYX (Biological) $285.80
- HUMIRA (Biological) $236.69
- Tremfya (Drug) $195.97
- DORYX (Drug) $169.18
- Xolegel (Drug) $149.81
- TALTZ (Drug) $141.66
- ILUMYA (Biological) $135.89
- STELARA (Biological) $125.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Brooklyn
Idan Sharon, M.d, M.D
Specialist — Payments: $2.3M
Specialist $2.3M
Dr. Sean Studer, M.d, M.D
Specialist — Payments: $411,591
Specialist $411,591
Dr. Michael Lewis, M.d, M.D
Specialist — Payments: $68,268
Specialist $68,268
Dr. Marc Avram, Md, MD
Specialist — Payments: $48,018
Specialist $48,018
Michael Amoashiy, Md, MD
Specialist — Payments: $41,408
Specialist $41,408
Dr. Madhavi Reddy, M.d, M.D
Specialist — Payments: $40,649
Specialist $40,649